Clinical trials for NON RARE IN EUROPE: Adenocarcinoma of stomach
45 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07431281Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2AstraZeneca
- ACTIVE NOT RECRUITINGNCT07448493Local Treatment Strategies for Brain Metastases of Gastric and Esophageal CancerBlokhin's Russian Cancer Research Center · PI: David Khalafyan, MD
- RECRUITINGPHASE1, PHASE2NCT07262619EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsEikon Therapeutics · PI: Nilou Mobashery, MD
- RECRUITINGPhase 2NCT07070466Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEAMassachusetts General Hospital · PI: Samuel Klempner, MD
- RECRUITINGPhase 2NCT07102901Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction AdenocarcinomaJiangsu HengRui Medicine Co., Ltd.
- RECRUITINGPhase 2NCT07212933The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled TrialChinese PLA General Hospital
- RECRUITINGNCT07032961A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies ScreeningNanfang Hospital, Southern Medical University
- RECRUITINGPHASE1, PHASE2NCT06710756Lead-212 PSV359 Therapy for Patients With Solid TumorsPerspective Therapeutics
- RECRUITINGPhase 2NCT06808971Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJCancer Institute and Hospital, Chinese Academy of Medical Sciences · PI: LIN YANG, Doctor
- RECRUITINGPhase 2NCT06250036Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric CancerRoyal Marsden NHS Foundation Trust · PI: Naureen Starling
- RECRUITINGPHASE1, PHASE2NCT06710132Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)EMD Serono Research & Development Institute, Inc. · PI: Medical Responsible
- RECRUITINGPhase 1NCT06783569A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid TumorsJiaRay Group
- ACTIVE NOT RECRUITINGNCT06504615Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in FranceBristol-Myers Squibb · PI: Bristol-Myers Squibb
- RECRUITINGN/ANCT07056010Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion ImmunochemotherapyThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE1, PHASE2NCT06532799TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal CancerEssen Biotech
- RECRUITINGNCT06982768How Epigenetic Changes in hMLH1 Connect Lab Research With Diagnosis in Gastric CancerFondazione Policlinico Universitario Agostino Gemelli IRCCS · PI: Annamaria Agnes
- RECRUITINGPhase 2NCT06580574Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon CancersPeking University · PI: Lin Shen
- RECRUITINGPHASE2, PHASE3NCT06203600Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialNational Cancer Institute (NCI) · PI: Anwaar Saeed
- RECRUITINGPhase 1NCT06253871A Phase 1/1b Study of IAM1363 in HER2 CancersIambic Therapeutics, Inc · PI: Iambic Therapeutics, Inc., Senior Medical Director
- RECRUITINGPhase 3NCT06296706A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · PI: Ruihua Xu, Doctor
- ACTIVE NOT RECRUITINGPhase 2NCT06256328A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)Ono Pharmaceutical Co. Ltd · PI: Project Leader
- RECRUITINGPhase 2NCT06383559Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer PatientsTianjin Medical University Cancer Institute and Hospital
- RECRUITINGPhase 1NCT06126406Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid TumorsChongqing Precision Biotech Co., Ltd · PI: lili Sheng, M.D
- RECRUITINGPHASE1, PHASE2NCT06006390CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid TumorsChongqing Precision Biotech Co., Ltd · PI: Qi Mei, M.D
- RECRUITINGPhase 2NCT05476796Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction CancerUNICANCER · PI: Christelle DE LA FOUCHARDIERE
- RECRUITINGPhase 2NCT05709574Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ CancerUniversity of Arizona · PI: Junaid Arshad, MD
- RECRUITINGPhase 2NCT06313801Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC SessionsNizhny Novgorod Regional Clinical Oncology Center · PI: Sergey Gamayunov, DMS
- ACTIVE NOT RECRUITINGPhase 1NCT05238883A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsHiFiBiO Therapeutics
- ACTIVE NOT RECRUITINGPhase 1NCT05075993Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsM.D. Anderson Cancer Center · PI: Siqing Fu
- RECRUITINGPhase 1NCT05107674A Study of NX-1607 in Adults With Advanced MalignanciesNurix Therapeutics, Inc. · PI: Linda Neuman, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04704661Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialNational Cancer Institute (NCI) · PI: Kanwal P Raghav
- RECRUITINGNCT04850729Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.Nanfang Hospital, Southern Medical University
- RECRUITINGN/ANCT04368702CONFIRM: Magnetic Resonance Guided Radiation TherapyBrigham and Women's Hospital · PI: Raymond Mak, MD
- RECRUITINGPhase 2NCT07178808PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCERBanner Health
- RECRUITINGNCT04557969Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic AnalysisNational Cancer Institute (NCI) · PI: Andrew M Blakely, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT03641313Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction CancerNational Cancer Institute (NCI) · PI: Jordan D Berlin
- ACTIVE NOT RECRUITINGPhase 2NCT04111172A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal AdenocarcinomaThomas Jefferson University · PI: Babar Bashir, MD
- ACTIVE NOT RECRUITINGN/ANCT04584008Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular CharacteristicsPeking University · PI: Lin Shen, MD
- RECRUITINGPhase 2NCT03935893Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersUdai Kammula · PI: Udai S Kammula, MD
- RECRUITINGN/ANCT04047953Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric AdenocarcinomaPeking University Cancer Hospital & Institute · PI: Jiafu ji, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03421288Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune ResponsivenessInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · PI: Salah-Eddin Al-Batran, Prof.
- RECRUITINGPhase 2NCT03161522Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerM.D. Anderson Cancer Center · PI: Quynh-Nhu Nguyen
- ACTIVE NOT RECRUITINGPhase 1NCT02496273Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric CancerThe First People's Hospital of Changzhou · PI: Wu Changping, M.D
- RECRUITINGNCT01416714Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or BiopsyUniversity of Chicago · PI: Daniel Catenacci, MD
- ACTIVE NOT RECRUITINGNCT06301464Pepsinogen II and Helicobacter Pylori Test in Gastric CancerSeoul National University Bundang Hospital · PI: Nayoung Kim, M.D., Ph.D.